SRBCF
Price:
$0.0557
Market Cap:
$20.46M
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. Sirona Biochem Corp. has a research collaboration agreement with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop antiviral library of compounds. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. The company was incorporated in 2006 an...[Read more]
Industry
Biotechnology
IPO Date
2013-02-12
Stock Exchange
PNK
Ticker
SRBCF
According to Sirona Biochem Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 23.74M. This represents a change of 15.08% compared to the average of 20.63M of the last 4 quarters.
The mean historical Enterprise Value of Sirona Biochem Corp. over the last ten years is 34.99M. The current 23.74M Enterprise Value has changed 6.69% with respect to the historical average. Over the past ten years (40 quarters), SRBCF's Enterprise Value was at its highest in in the October 2019 quarter at 98.33M. The Enterprise Value was at its lowest in in the October 2014 quarter at 14.08M.
Average
34.99M
Median
27.53M
Minimum
13.33M
Maximum
86.82M
Discovering the peaks and valleys of Sirona Biochem Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 354.62%
Maximum Annual Enterprise Value = 86.82M
Minimum Annual Increase = -35.67%
Minimum Annual Enterprise Value = 13.33M
Year | Enterprise Value | Change |
---|---|---|
2023 | 20.32M | -31.34% |
2022 | 29.60M | -33.93% |
2021 | 44.81M | -19.78% |
2020 | 55.85M | -35.67% |
2019 | 86.82M | 354.62% |
2018 | 19.10M | -23.63% |
2017 | 25.01M | -12.50% |
2016 | 28.58M | 7.95% |
2015 | 26.47M | 98.59% |
2014 | 13.33M | 7.26% |
The current Enterprise Value of Sirona Biochem Corp. (SRBCF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
31.58M
5-year avg
47.48M
10-year avg
34.99M
Sirona Biochem Corp.’s Enterprise Value is less than Adynxx, Inc. (0), greater than NLS Pharmaceutics AG (581.00), greater than Ascletis Pharma Inc. (9.64M), less than Surrozen, Inc. (916.46M), greater than Bolt Biotherapeutics, Inc. (250.67K), less than Larimar Therapeutics, Inc. (30.96M), less than Keros Therapeutics, Inc. (363.34M), less than Kezar Life Sciences, Inc. (1.75B), less than Coya Therapeutics, Inc. (36.78M), less than Cue Biopharma, Inc. (77.54M), less than Lantern Pharma Inc. (41.71M), less than Fennec Pharmaceuticals Inc. (25.41M), less than Eliem Therapeutics, Inc. (105.60M), less than SciSparc Ltd. (119.64M), greater than OncoSec Medical Incorporated (540.60K), greater than Virax Biolabs Group Limited (-4472153.00), greater than Hillstream BioPharma, Inc. (5.36M), greater than ZyVersa Therapeutics, Inc. (1.48M), greater than Eiger BioPharmaceuticals, Inc. (2.53M), greater than Spruce Biosciences, Inc. (18.32M), greater than Werewolf Therapeutics, Inc. (-36863453.00), greater than Unicycive Therapeutics, Inc. (-1378920.00), greater than Fusion Pharmaceuticals Inc. (23.47M), less than null (1.87B),
Company | Enterprise Value | Market cap |
---|---|---|
0 | $581.00 | |
581.00 | $8.19M | |
9.64M | $172.62M | |
916.46M | $29.74M | |
250.67K | $22.14M | |
30.96M | $393.05M | |
363.34M | $2.27B | |
1.75B | $54.72M | |
36.78M | $108.60M | |
77.54M | $64.62M | |
41.71M | $33.22M | |
25.41M | $145.92M | |
105.60M | $342.68M | |
119.64M | $2.54M | |
540.60K | $1.65M | |
-4472153.00 | $8.73M | |
5.36M | $4.17M | |
1.48M | $2.65M | |
2.53M | $2.55M | |
18.32M | $19.96M | |
-36863453.00 | $84.67M | |
-1378920.00 | $55.01M | |
23.47M | $1.83B | |
1.87B | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sirona Biochem Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sirona Biochem Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Sirona Biochem Corp.'s Enterprise Value?
What is the highest Enterprise Value for Sirona Biochem Corp. (SRBCF)?
What is the 3-year average Enterprise Value for Sirona Biochem Corp. (SRBCF)?
What is the 5-year average Enterprise Value for Sirona Biochem Corp. (SRBCF)?
How does the current Enterprise Value for Sirona Biochem Corp. (SRBCF) compare to its historical average?